iVascularU

iVascular is a privately-held, commercial-stage medical device company focused on the cardiovascular and neurovascular markets. Leveraging deep expertise in biopolymers, coatings, and drug delivery, the company has built a vertically integrated platform to develop and manufacture a portfolio of interventional devices, including the Angiolite drug-eluting stent and Luminor drug-coated balloon. With products approved in over 70 countries and a growing clinical evidence base, iVascular aims to be a European reference in vascular therapy through innovation and close collaboration with physicians.

Vertically integrated platform for developing medical devices, including proprietary stent design, catheter extrusion, polymer synthesis, and drug-coating technologies. Controls entire process from raw materials (plastic pellets) to finished product, supported by proprietary quality control systems like the 'Q six' automatic microscope.

iVascular competes in the crowded vascular device market against major players like Abbott, Boston Scientific, Medtronic, and BD, as well as specialized companies like Biotronik, Cook Medical, and Philips. Its differentiation lies in vertical integration, European manufacturing, and a focused portfolio across three vascular beds. Competition is based on clinical data, physician relationships, product efficacy, and price.